schedule

2014 National Immunisation Schedule

New and updated resources for the 2014 National Immunisation Schedule

(in effect from 1 July)

 Indicates a resource containing technical content written for a health professional audience.

Most of these resources are PDF files. Click the Adobe Reader image to visit the Adobe website and download the free PDF file viewer software .

Ministry of Health
 2014 Immunisation Schedule change (links to Ministry of Health website)
Immunisation Handbook 2014 (links to Ministry of Health website)
  Additional funded vaccines for special groups
  Schedule from 1 July
  Rotavirus and the RotaTeq vaccine
  Immunisation Update May 2014 (GP fax)
  Immunisation Update June 2014 (GP fax)

 

Ministry of Health/Changes to the Immunisation Handbook 2014
  Page 680 - Funded vaccines for special groups, 6 June 2014 
  Multiple changes - May to 6 June 2014

 

Ministry of Health/Health Ed
(available for order through the HealthEd website)
  After your child is immunised (A5 leaflet HE1504)
  Childhood immunisation (A5 booklet HE1323)
  Immunisation certificate (A5 leaflet HE7013)  
  Immunisation record (A5 sticker for Well Child Tamariki Ora Book HE1309)
  Immunise against rotavirus - Protect you child (Pamplet HE2425)
  Immunise your child on time (Leaflet HE1327)
  Protect your child (Poster HE1221)
  Protect your new baby from rotavirus (Poster HE2426)
  Travelling? Think measles (A4 poster HP5935)
  Vaccines for the National Immunisation Schedule (A4 card HE1308)
  Well Child Tamariki Ora - My health book (A5 parent-held book HE7012)

 

ImmNuZ
  ImmNuZ - Issue 77 - June 2014
  ImmNuZ - Issue 78 - August 2014

 

 

IMAC
  2014 National Immunisation Schedule (A4 double sided card, only soft copy available to download)
  2014 National Immunisation Schedule changes (fact sheet)

  2014 National Immunisation Schedule training (a PowerPoint presentation in pdf format)

       Contact your Local Immunisation Coordinator if you require the PowerPoint presentation.

  Chickenpox (Varicella)
  Chickenpox (Varicella) reference list
  Immunisation for the low birth weight and/or preterm infant
  Pneumococcal disease
  Rotavirus (updated September 2014)
  Rotavirus reference list
  Management of tetanus-prone wounds (updated August 2014) 
  Vaccine ingredients

 

PHARMAC 2014 Schedule - eligibility criteria changes
 Changes to access criteria - 6 June 2014

 

 

 

 

 

 

 

IPOL

IPV

IPOL is used for primary and booster vaccination of infants, children and adults to protect against infection with Type 1, Type 2 and Type 3 polioviruses causing poliomyelitis.

M-M-R® II

MMR

M-M-R® II is used for primary vaccination and revaccination of children and adults to protect against measles, mumps and rubella.

Act-HIB™

Haemophillus influenzae type b (Hib)

Act-HIB™ is used for primary and booster vaccination of infants and children up to their 5th birthday to protect against disease caused by Haemophilus influenzae type b.The vaccine is also used for primary vaccination of children aged 5 years of age and over and adults with some chronic medical conditions. Act-HIB™ is licensed for use in infants and children 2 months to 5 years of age. It is used out of licensure in children 5 years of age and over and adults as there is no alternative vaccine available in New Zealand for these age groups. When children/individuals are older than the age to which the vaccine is licensed, use will be outside of current licensure. No safety concerns are expected for use in older age groups.

ADT™ Booster

Td

ADT™ Booster is used for primary and booster vaccination of children 7 years of age and over and adults to protect against tetanus and diphtheria. An alternative vaccine called Boostrix®, which protects against tetanus, diphtheria and pertussis (whooping cough), can be substituted for one, two or all three doses of the primary vaccinations in these age groups. Both ADT™ Booster and Boostrix® are licensed as booster vaccines. They are used for primary vaccination out of licensure as there is no alternative primary vaccination strength vaccine available in New Zealand for these age groups. When the vaccine is used for a primary vaccination course, use will be outside of current licensure. No safety concerns are expected with use in these circumstances.

Infanrix®-IPV

DTaP-IPV

Infanrix®-IPV is used for primary and booster vaccination of infants and children to protect against diphtheria, tetanus, pertussis and poliomyelitis. Infanrix®-IPV can also be used for catch-up immunisation for children up to their 10th birthday.

Gardasil®

Human papillomavirus (HPV)

Gardasil® is funded for use for primary immunisation of girls from 9 years of age and young women to protect them from four types of human papillomavirus infection, HIV positive individuals aged 9-26 years, and individuals who are pre- or post-solid organ transplantation. Gardasil® is not funded but can be used for primary immunisation of females who are not eligible for funded vaccine and within the age group of 9 through 45 years and males aged 9 through 26 years to protect them from four types of human papillomavirus infection.

The Institute of Environmental Science & Research Limited (ESR)Sexually transmitted infections in New Zealand 2011 Surveillance Report identified decreasing numbers of new genital warts cases between 2008 and 2011, most notable in 2010 and 2011 and in females aged 15-19 years, corresponding with commencement of the HPV immunisation programme. The Genital Warts pages from the full report are available here. The full ESR report is available from the ESR Public Health Surveillance website.

A short YouTube DVD, The Story of HPV (Human Papillomavirus), provides information for women, parents and caregivers, health workers and students planning to work in the health sector about the human papillomavirus, the Gardasil® vaccine that helps to protect against HPV, and the importance of cervical screening and practising safer sex in protecting women's health.

Synflorix®

PCV10

Synflorix® is used for primary and booster vaccination of infants and children up to their 5th birthday to protect against disease caused by 10 types of streptococcus pneumoniae.

Infanrix®-hexa

DTaP-IPV-HepB/Hib

Infanrix®-hexa is used for primary and booster vaccination of infants and children to protect against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and disease caused by Haemophilus influenzae type b. Infanrix®-hexa can also be used for catch-up immunisation for children up to their 10th birthday.

 

Boostrix®

Tdap

Boostrix® is used for booster vaccination of adolescents aged 11 years and pregnant women between 28-38 weeks gestation* to protect against diphtheria, tetanus and pertussis (whooping cough). Boostrix® can also be used for catch-up immunisation for children aged 7 years# to under 18 years.

*After immunisation protection against pertussis takes up to two weeks to develop. Whilst immunisation between 38-40 weeks gestation is still safe for mother and baby later immunisation means the newborn may still be exposed to the disease by their mother on delivery and/or during the first two weeks of life. The PHARMAC decision to limit funded Boostrix® to 28-38 weeks gestation maximises the benefit of immunisation against pertussis whilst being accountable for the use of public funds. Pregnant women can choose to purchase Boostrix® privately after 38 weeks gestation or at any time after delivery.

#Although Boostrix® is not licensed for use in children aged 7 years to under 10 years it has been used in New Zealand and overseas in this age group and there are no safety concerns with off-label use.

Subscribe to RSS - schedule